| 发明名称 |
EPIGENETIC SILENCING OF CYCLOOXYGENASE-2 AFFECTS CLINICAL OUTCOME IN GASTRIC CANCER |
| 摘要 |
The present invention discloses methods of using the methylation status of the COX-2 gene promoter region as a biomarker for a gastric cancer patient to determine a prognosis and a treatment regimen, and to monitor the progress of a treatment regimen.
|
| 申请公布号 |
CA2690879(A1) |
申请公布日期 |
2008.12.24 |
| 申请号 |
CA20082690879 |
申请日期 |
2008.06.13 |
| 申请人 |
JOHN WAYNE CANCER INSTITUTE |
发明人 |
HOON, DAVE S. B.;DE MAAT, MICHIEL |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
